Artificial heart offers hope for transplant candidates

NCT ID NCT04475393

Ongoing Disease control Sponsor: Carmat SAS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing the Carmat Total Artificial Heart in 104 people with severe, irreversible heart failure who are waiting for a heart transplant. The device is designed to replace both heart chambers and keep patients alive until a donor heart becomes available. Researchers are measuring how many patients survive without major complications like disabling stroke or device failure for 180 days after implantation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED HEART FAILURE

Contacts and locations

Show contact details

Locations

CHRU Montpellier

Montpellier, 34090, France
CHU Dijon

Dijon, 21000, France
Centre Hospitalier Régional Universitaire

Lille, 59000, France
Groupe Hospitalier Pitié-Salpêtrière,

Paris, 75013, France
Hôpital Européen George Pompidou

Paris, 75015, France
Hôpital Laennec

Nantes, 44093, France
Hôpital Louis Pradel

Bron, 69500, France
Hôpital Marie Lannelongue

Le Plessis-Robinson, 92350, France
Hôpital Pontchaillou

Rennes, 35033, France
Nouvel Hôpital Civil

Strasbourg, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.